Feedback / Questions
Minerval (idroxioleic acid) - Laminar Pharma
https://www.prnewswire.com/news-releases/laminar-pharma-announces-first-open-label-progression-free-survival-data-for-lam561-in-combination-with-standard-of-care-in-first-line-therapy-for-newly-diagnosed-glioblastoma-mgmt-methylated-patients-302393021.html
Mar 5, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next